195 related articles for article (PubMed ID: 38782984)
1. Proteome-wide Mendelian randomization identifies potential therapeutic targets for nonalcoholic fatty liver diseases.
Li J; Ma X; Yin C
Sci Rep; 2024 May; 14(1):11814. PubMed ID: 38782984
[TBL] [Abstract][Full Text] [Related]
2. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
Yang C; Fagan AM; Perrin RJ; Rhinn H; Harari O; Cruchaga C
Genome Med; 2022 Dec; 14(1):140. PubMed ID: 36510323
[TBL] [Abstract][Full Text] [Related]
3. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.
Zhang L; Xiong Y; Zhang J; Feng Y; Xu A
J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019
[TBL] [Abstract][Full Text] [Related]
4. Genetic associations in ankylosing spondylitis: circulating proteins as drug targets and biomarkers.
Zhang Y; Liu W; Lai J; Zeng H
Front Immunol; 2024; 15():1394438. PubMed ID: 38835753
[TBL] [Abstract][Full Text] [Related]
5. Type 1 diabetes mellitus and non-alcoholic fatty liver disease: a two-sample Mendelian randomization study.
Tuo L; Yan LT; Liu Y; Yang XX
Front Endocrinol (Lausanne); 2024; 15():1315046. PubMed ID: 38681765
[TBL] [Abstract][Full Text] [Related]
6. Proteome-Wide Mendelian Randomization and Colocalization Analysis Identify Therapeutic Targets for Knee and Hip Osteoarthritis.
Zou M; Shao Z
Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540773
[TBL] [Abstract][Full Text] [Related]
7. Exploration of the core pathway of inflammatory bowel disease complicated with metabolic fatty liver and two-sample Mendelian randomization study of the causal relationships behind the disease.
Wei Z; Wang J
Front Immunol; 2024; 15():1375654. PubMed ID: 38698841
[TBL] [Abstract][Full Text] [Related]
8. [Nonalcoholic fatty liver disease and risk of erectile dysfunction: A bidirectional two-sample mendelian randomization study].
Cheng P; Wang YW; Shen YJ
Zhonghua Nan Ke Xue; 2023 Aug; 29(8):705-710. PubMed ID: 38619516
[TBL] [Abstract][Full Text] [Related]
9. Circulating Galectin-3 Levels Are Not Associated With Nonalcoholic Fatty Liver Disease: A Mendelian Randomization Study.
Tremblay M; Perrot N; Ghodsian N; Gobeil É; Couture C; Mitchell PL; Thériault S; Arsenault BJ
J Clin Endocrinol Metab; 2021 Jul; 106(8):e3178-e3184. PubMed ID: 33693708
[TBL] [Abstract][Full Text] [Related]
10. Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization.
King SD; Veliginti S; Brouwers MCGJ; Ren Z; Zheng W; Setiawan VW; Wilkens LR; Shu XO; Arslan AA; Beane Freeman LE; Bracci PM; Canzian F; Du M; Gallinger SJ; Giles GG; Goodman PJ; Haiman CA; Kogevinas M; Kooperberg C; LeMarchand L; Neale RE; Visvanathan K; White E; Albanes D; Andreotti G; Babic A; Berndt SI; Brais LK; Brennan P; Buring JE; Rabe KG; Bamlet WR; Chanock SJ; Fuchs CS; Gaziano JM; Giovannucci EL; Hackert T; Hassan MM; Katzke V; Kurtz RC; Lee IM; Malats N; Murphy N; Oberg AL; Orlow I; Porta M; Real FX; Rothman N; Sesso HD; Silverman DT; Thompson IM; Wactawski-Wende J; Wang X; Wentzensen N; Yu H; Zeleniuch-Jacquotte A; Yu K; Wolpin BM; Duell EJ; Li D; Hung RJ; Perdomo S; McCullough ML; Freedman ND; Patel AV; Peters U; Riboli E; Sund M; Tjønneland A; Zhong J; Van Den Eeden SK; Kraft P; Risch HA; Amundadottir LT; Klein AP; Stolzenberg-Solomon RZ; Antwi SO
Cancer Epidemiol Biomarkers Prev; 2023 Sep; 32(9):1265-1269. PubMed ID: 37351909
[TBL] [Abstract][Full Text] [Related]
11. Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease: A 2-Sample Bidirectional Mendelian Randomization Study.
Li S; Fu Y; Liu Y; Zhang X; Li H; Tian L; Zhuo L; Liu M; Cui J
J Clin Endocrinol Metab; 2022 Jul; 107(8):e3497-e3503. PubMed ID: 35363278
[TBL] [Abstract][Full Text] [Related]
12. Exploring the interconnected between type 2 diabetes mellitus and nonalcoholic fatty liver disease: Genetic correlation and Mendelian randomization analysis.
Ni W; Lu Y; Wang W
Medicine (Baltimore); 2024 May; 103(19):e38008. PubMed ID: 38728519
[TBL] [Abstract][Full Text] [Related]
13. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases.
Zheng J; Haberland V; Baird D; Walker V; Haycock PC; Hurle MR; Gutteridge A; Erola P; Liu Y; Luo S; Robinson J; Richardson TG; Staley JR; Elsworth B; Burgess S; Sun BB; Danesh J; Runz H; Maranville JC; Martin HM; Yarmolinsky J; Laurin C; Holmes MV; Liu JZ; Estrada K; Santos R; McCarthy L; Waterworth D; Nelson MR; Smith GD; Butterworth AS; Hemani G; Scott RA; Gaunt TR
Nat Genet; 2020 Oct; 52(10):1122-1131. PubMed ID: 32895551
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D and Nonalcoholic Fatty Liver Disease: Bi-directional Mendelian Randomization Analysis.
Wang N; Chen C; Zhao L; Chen Y; Han B; Xia F; Cheng J; Li Q; Lu Y
EBioMedicine; 2018 Feb; 28():187-193. PubMed ID: 29339098
[TBL] [Abstract][Full Text] [Related]
15. Causal effects from non-alcoholic fatty liver disease on kidney function: A Mendelian randomization study.
Park S; Lee S; Kim Y; Cho S; Kim K; Chul Kim Y; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
Liver Int; 2022 Feb; 42(2):412-418. PubMed ID: 34843158
[TBL] [Abstract][Full Text] [Related]
16. Mendelian randomization suggests a causal relationship between gut microbiota and nonalcoholic fatty liver disease in humans.
Dai X; Jiang K; Ma X; Hu H; Mo X; Huang K; Jiang Q; Chen Y; Liu C
Medicine (Baltimore); 2024 Mar; 103(12):e37478. PubMed ID: 38518048
[TBL] [Abstract][Full Text] [Related]
17. Role of Inflammatory Factors in Mediating the Effect of Lipids on Nonalcoholic Fatty Liver Disease: A Two-Step, Multivariable Mendelian Randomization Study.
Chen J; Zhou H; Jin H; Liu K
Nutrients; 2022 Oct; 14(20):. PubMed ID: 36297117
[TBL] [Abstract][Full Text] [Related]
18. Mendelian randomization analysis identifies druggable genes and drugs repurposing for chronic obstructive pulmonary disease.
Wang Z; Li S; Cai G; Gao Y; Yang H; Li Y; Liang J; Zhang S; Hu J; Zheng J
Front Cell Infect Microbiol; 2024; 14():1386506. PubMed ID: 38660492
[TBL] [Abstract][Full Text] [Related]
19. Non-alcoholic fatty liver disease and gestational diabetes mellitus: a bidirectional two-sample mendelian randomization study.
Zhou BG; Xia JL; Jiang X; Ding YB; She Q
BMC Endocr Disord; 2024 Mar; 24(1):40. PubMed ID: 38504196
[TBL] [Abstract][Full Text] [Related]
20. Proteome-wide Mendelian randomization identifies therapeutic targets for ankylosing spondylitis.
Zhao W; Fang P; Lai C; Xu X; Wang Y; Liu H; Jiang H; Liu X; Liu J
Front Immunol; 2024; 15():1366736. PubMed ID: 38566994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
